Fairfield, Bush & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-15,265
Closed -$1.52M 155
2019
Q3
$1.52M Hold
15,265
0.52% 48
2019
Q2
$1.41M Sell
15,265
-1,945
-11% -$180K 0.48% 49
2019
Q1
$1.62M Buy
17,210
+150
+0.9% +$14.2K 0.54% 46
2018
Q4
$1.09M Sell
17,060
-1,450
-8% -$92.9K 0.38% 52
2018
Q3
$1.66M Buy
18,510
+2,700
+17% +$242K 0.46% 50
2018
Q2
$1.26M Sell
15,810
-1,760
-10% -$140K 0.37% 56
2018
Q1
$1.57M Buy
17,570
+1,545
+10% +$138K 0.46% 49
2017
Q4
$1.67M Buy
16,025
+2,945
+23% +$307K 0.46% 49
2017
Q3
$1.91M Hold
13,080
0.6% 40
2017
Q2
$1.7M Hold
13,080
0.54% 44
2017
Q1
$1.63M Hold
13,080
0.51% 45
2016
Q4
$1.51M Hold
13,080
0.49% 48
2016
Q3
$1.37M Sell
13,080
-655
-5% -$68.5K 0.44% 51
2016
Q2
$1.36M Buy
13,735
+3,200
+30% +$316K 0.47% 47
2016
Q1
$1.05M Sell
10,535
-1,125
-10% -$113K 0.38% 51
2015
Q4
$1.4M Buy
11,660
+6,155
+112% +$737K 0.49% 50
2015
Q3
$595K Sell
5,505
-2,350
-30% -$254K 0.26% 68
2015
Q2
$909K Buy
7,855
+75
+1% +$8.68K 0.27% 75
2015
Q1
$897K Buy
7,780
+520
+7% +$60K 0.26% 78
2014
Q4
$812K Buy
7,260
+4,900
+208% +$548K 0.23% 82
2014
Q3
$224K Buy
+2,360
New +$224K 0.06% 162